Literature DB >> 2786145

Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire.

R W Ryder1, W Nsa, S E Hassig, F Behets, M Rayfield, B Ekungola, A M Nelson, U Mulenda, H Francis, K Mwandagalirwa.   

Abstract

To examine perinatal transmission of the human immunodeficiency virus type 1 (HIV-1) in Zaire, we screened 8108 women who gave birth at one of two Kinshasa hospitals that serve populations of markedly different socioeconomic status. For up to one year, we followed the 475 infants of the 466 seropositive women (5.8 percent of those screened) and the 616 infants of 606 seronegative women matched for age, parity, and hospital. On the basis of clinical criteria, 85 of the seropositive women (18 percent) had the acquired immunodeficiency syndrome (AIDS). The infants of seropositive mothers, as compared with those of seronegative mothers, were more frequently premature, had lower birth weights, and had a higher death rate in the first 28 days (6.2 vs. 1.2 percent; P less than 0.0001). The patterns were similar at the two hospitals. Twenty-one percent of the cultures for HIV-1 of 92 randomly selected cord-blood samples from infants of seropositive women were positive. T4-cell counts were performed in 37 seropositive women, and cord blood from their infants was cultured. The cultures were positive in the infants of 6 of the 18 women with antepartum T4 counts of 400 or fewer cells per cubic millimeter, as compared with none of the infants of the 19 women with more than 400 T4 cells per cubic millimeter (P = 0.02). One year later, 21 percent of the infants of the seropositive mothers had died as compared with 3.8 percent of the control infants (P less than 0.001), and 7.9 percent of their surviving infants had AIDS. We conclude that the mortality rates among children of seropositive mothers are high regardless of socioeconomic status, and that perinatal transmission of HIV-1 has a major adverse effect on infant survival in Kinshasa.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Age Factors; Antibodies--analysis; Biology; Birth Weight; Body Weight; Data Analysis; Demographic Factors; Developing Countries; Diseases; Examinations And Diagnoses; Fertility; Fertility Measurements; French Speaking Africa; Hiv Infections--transmission; Immunity; Immunologic Factors; Incidence; Infant; Infant Mortality; Laboratory Examinations And Diagnoses; Laboratory Procedures; Measurement; Middle Africa; Mortality; Physiology; Population; Population Characteristics; Population Dynamics; Pregnancy; Pregnancy History; Pregnancy Outcomes; Reproduction; Research Methodology; Viral Diseases; Youth; Zaire

Mesh:

Year:  1989        PMID: 2786145     DOI: 10.1056/NEJM198906223202501

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  60 in total

Review 1.  Sexually transmitted diseases in children: HIV infection.

Authors:  J Y Mok
Journal:  Genitourin Med       Date:  1992-10

Review 2.  Sexually transmitted diseases in children: introduction.

Authors:  S Estreich; G E Forster
Journal:  Genitourin Med       Date:  1992-02

Review 3.  AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease.

Authors:  D M Mitchell; R F Miller
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

4.  Simian immunodeficiency virus infection in wild-caught chimpanzees from cameroon.

Authors:  Eric Nerrienet; Mario L Santiago; Yacouba Foupouapouognigni; Elizabeth Bailes; Nicolas I Mundy; Bernadette Njinku; Anfumbom Kfutwah; Michaela C Muller-Trutwin; Françoise Barre-Sinoussi; George M Shaw; Paul M Sharp; Beatrice H Hahn; Ahidjo Ayouba
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  HIV-1 infection and perinatal mortality in Zimbabwe.

Authors:  C G Aiken
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

6.  Zidovudine pharmacokinetics in premature infants exposed to human immunodeficiency virus.

Authors:  M Mirochnick; E Capparelli; W Dankner; R S Sperling; R van Dyke; S A Spector
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

7.  Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factor.

Authors:  D A Dibbern; G W Glazner; I Gozes; D E Brenneman; J M Hill
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

8.  Up-regulation of CCR5 expression in the placenta is associated with human immunodeficiency virus-1 vertical transmission.

Authors:  H Behbahani; E Popek; P Garcia; J Andersson; A L Spetz; A Landay; Z Flener; B K Patterson
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

9.  Estimating the rate of mother-to-child transmission of HIV. Report of a workshop on methodological issues Ghent (Belgium), 17-20 February 1992. The Working Group on Mother-to-Child Transmission of HIV.

Authors:  F Dabis; P Msellati; D Dunn; P Lepage; M L Newell; C Peckham; P Van de Perre
Journal:  AIDS       Date:  1993-08       Impact factor: 4.177

10.  Immunoglobulins and growth parameters at birth of infants born to HIV seropositive and seronegative women.

Authors:  A Butz; N Hutton; E Larson
Journal:  Am J Public Health       Date:  1991-10       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.